Sensei Biotherapeutics, Inc.
SNSE
$0.3857
-$0.0192-4.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -33.02% | -0.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.34% | 0.46% | |||
| Operating Income | 15.34% | -0.46% | |||
| Income Before Tax | -7.13% | -1.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.13% | -1.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.13% | -1.55% | |||
| EBIT | 15.34% | -0.46% | |||
| EBITDA | 16.01% | -0.43% | |||
| EPS Basic | -7.04% | -1.37% | |||
| Normalized Basic EPS | 10.93% | -1.41% | |||
| EPS Diluted | -7.04% | -1.37% | |||
| Normalized Diluted EPS | 10.93% | -1.41% | |||
| Average Basic Shares Outstanding | 0.08% | 0.17% | |||
| Average Diluted Shares Outstanding | 0.08% | 0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||